In-house and External Retrospective Research Studies Incorporating ProEx C Biomarkers Presented at 53rd Annual Scientific Meeting of the American Society of Cytopathology BURLINGTON, N.C., Nov. 7 /PRNewswire-FirstCall/ -- TriPath Imaging, Inc. (NASDAQ:TPTH) today announced that the results of a new in-house retrospective research study demonstrated that testing of cervical cytology specimens with Research Use Only (RUO) reagents incorporating the Company's proprietary ProEx C biomarkers yielded a 93% (p
Tripath Imaging (NASDAQ:TPTH)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Tripath Imaging Charts.
Tripath Imaging (NASDAQ:TPTH)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Tripath Imaging Charts.